Evidence map›Paper›PMID 25942440›Full record

ArticlePloS one2015

Antiviral Effects of Novel Herbal Medicine KIOM-C, on Diverse Viruses.

Melbourne R Talactac, Mohammed Y E Chowdhury, Min-Eun Park, Prasanna Weeratunga, Tae-Hwan Kim, Won-Kyung Cho, Chul-Joong Kim, Jin Yeul Ma, Jong-Soo Lee

RetractedOpen access · goldAbstract readRetracted Publication
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Herbal Medication to Enhance or Modulate Viral Infections.The Nursing clinics of North America · 2021
    Review
  4. Article
  5. Article
  6. Protective Effect ofFrontiers in immunology · 2017
    Article
  7. Frontiers in pharmacology · 2017
    Article
  8. Article
  9. Frontiers in pharmacology · 2016
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Melbourne R TalactacCollege of Veterinary Medicine, Chungnam National University, Daejeon, Republic of Korea; College of Veterinary Medicine and Biomedical Sciences, Cavite State University, Cavite, Philippines.
Mohammed Y E ChowdhuryCollege of Veterinary Medicine, Chungnam National University, Daejeon, Republic of Korea; Faculty of Veterinary Medicine, Chittagong Veterinary and Animal Sciences University, Chittagong, Bangladesh.
Min-Eun ParkCollege of Veterinary Medicine, Chungnam National University, Daejeon, Republic of Korea.
Prasanna WeeratungaCollege of Veterinary Medicine, Chungnam National University, Daejeon, Republic of Korea.
Tae-Hwan KimCollege of Veterinary Medicine, Chungnam National University, Daejeon, Republic of Korea.
Won-Kyung ChoKorean Medicine (KM) Based Herbal Drug Development Group, Korea Institute of Oriental Medicine, Deajeon, and Republic of Korea.
Chul-Joong KimCollege of Veterinary Medicine, Chungnam National University, Daejeon, Republic of Korea.
Jin Yeul MaKorean Medicine (KM) Based Herbal Drug Development Group, Korea Institute of Oriental Medicine, Deajeon, and Republic of Korea.
Jong-Soo LeeCollege of Veterinary Medicine, Chungnam National University, Daejeon, Republic of Korea.
Chungnam National University · KRKorea Institute of Oriental Medicine · KRCavite State University · PH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In order to identify new potential antiviral agents, recent studies have advocated thorough testing of herbal medicines or natural substances that are traditionally used to prevent viral infections. Antiviral activities and the mechanism of action of the total aqueous extract preparation of KIOM-C, a novel herbal medicine, against diverse types of viruses were investigated. In vitro antiviral activity against A/Puerto Rico/8/34 (H1N1) (PR8), vesicular stomatitis virus (VSV), and Newcastle disease virus (NDV) through the induction of type-I interferon related protein phosphorylation and up-regulation of pro-inflammatory cytokines in murine macrophage cells (RAW264.7) were determined. In vivo, KIOM-C-treated BALB/c mice showed higher survivability and lower lung viral titers when challenged with A/Aquatic bird/Korea/W81/2005 (H5N2), A/PR/8/34(H1N1), A/Aquatic bird/Korea/W44/2005(H7N3) or A/Chicken/Korea/116 /2004(H9N2) influenza subtypes in contrast with the non-treated group. The present study revealed that total aqueous extract preparation of KIOM-C stimulates an antiviral state in murine macrophage cells and in mice leading to inhibition of viral infection and protection against lethal challenges.

Indexed as

Herbal MedicineAnimalsAntiviral AgentsCell LineCells, CulturedCytokinesDisease Models, AnimalFemaleInflammation MediatorsInterferon Type ILungMiceOrthomyxoviridae InfectionsPlant ExtractsSignal TransductionVirusesAntiviral AgentsCytokinesInflammation MediatorsInterferon Type IKIOM-C preparationPlant Extracts

Identifiers

PMID25942440
PMCPMC4420246
OpenAlexW258267014

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.